Biomarin – Shanbally, Cork

BioMarin is a global biotechnology company that develops and commercialises innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The Shanbally facility opened in 2011 and employs over 350 people. In 2017 BioMarin completed an expanded warehouse, new administration and utilities offices, a canteen and conference facilities at Shanbally, while 2018 saw the completion of a Waste Water Pre-treatment Plant at the site and a new Bio-Assay Laboratory is currently being commissioned.

In September 2018 BioMarin announced that it is investing in a new Drug Product Filling Project at it’s Co. Cork facility.  This project will allow the company to maximise the flexibility of the site with the expansion of the operational manufacturing capacity to meet the rise in the global demand for its therapies to treat rare genetic diseases that mostly affect children.

 

 

The Latest BioMarin News

Biomarin Ireland

BioMarin expands its Cork facility with €37m investment

A LEADING drugs firm has confirmed a €40 million investment at their Cork plant with the creation of 51 new jobs. BioMarin unveiled plans to develop a new drug product filling facility at their plant at Shanbally outside Ringaskiddy in Cork. The investment will bring to BioMarin’s workforce to more than 400 people at Shanbally.

Read More

amgen limerick

BioMarin Opens New Dublin HQ

BioMarin, a drug group that focuses on treating patients with rare genetic disorders, many of them affecting children, opens a new Dublin headquarters for the EMEA region on Wednesday in a move that doubles the numbers employed.

Read More

LSC Newsletter

Sign Up To Our Newsletter For More Industry Updates

We send out a monthly newsletter with the latest project opportunities and industry news.

Sign Up Here

Contracting as a career choice
Read More
LSC’s commitment to contractor support
Read More
Explore jobs with LSC
Search Jobs